We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
ABIOMED, Inc. May 22 announced that the French regulatory agency for medical devices, the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSAPS) has granted approval of the AB5000(TM) Circulatory Support System.
The US Food and Drug Administration (FDA) has approved IONSYS(TM) (fentanyl iontophoretic transdermal system), the first needle-free, patient-activated analgesic system.
Cardinal Health, a provider of health care products and services, has completed its acquisition of Golden, Colorado-based Denver Biomedical, the firm said yesterday.
Healthcare equipment manufacturer EuroCOR, the wholly owned subsidiary of Opto Circuits Ltd, has signed a distribution agreement with a distributor in Brazil to cover the Latin American markets for marketing its drug-eluting stent Taxcor, reports Business Line.
After several discussions with Boston Scientific representatives, city officials approved a 20-year tax break agreement with the global medical devices corporation.
Data from two brain imaging studies of patients who received vagus nerve stimulation (VNS) therapy for treatment-resistant depression (TRD) are part of an "increasing body of evidence" of the treatment's benefit, Cyberonics said May 25.
HHS' Office of Inspector General (OIG) has entered into a settlement agreement and corporate integrity agreement (CIA) with Lincare Holdings and its subsidiary Lincare, the agency announced May 15.
Indian Healthcare equipment manufacturer Opto Circuits on Tuesday said its subsidiary EuroCOR GmbH has signed a Rs 135 million (US $2.9 million) deal with Brazil-based distributors to market its drug-eluting stent TAXCOR in Latin America.
UTEK Corporation, a specialty finance company focused on technology transfer, and Advanced Medical Isotope Corporation, symbol change pending, engaged in the development of advanced isotopes to be used in the diagnosis and treatment of disease, announced today that they have signed a strategic alliance agreement.